Stephanie Bonilla, | |
1318 N Avalon Blvd, Wilmington, CA 90744-2639 | |
(310) 549-2710 | |
(310) 549-2715 |
Full Name | Stephanie Bonilla |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 1318 N Avalon Blvd, Wilmington, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316477250 | NPI | - | NPPES |
6197-R | Medicaid | CA |
Mailing Address | Practice Location Address |
---|---|
Stephanie Bonilla, 1318 N Avalon Blvd, Wilmington, CA 90744-2639 Ph: (310) 549-2710 | Stephanie Bonilla, 1318 N Avalon Blvd, Wilmington, CA 90744-2639 Ph: (310) 549-2710 |
News Archive
Royal Philips today launched the results of the first edition of its Future Health Index (FHI), an extensive international study which explores how countries around the world are positioned to meet long-term global health challenges through integration and connected care technologies.
Dispositional, or "everyday" mindfulness is the inherent trait of being aware of one's present thoughts and feelings. In a new study of 399 people that measured health indicators including dispositional mindfulness and blood glucose, researchers found that those with higher scores for mindfulness were significantly more likely than people with low scores to have healthy glucose levels.
E-cigarettes have become increasingly popular as a smoke-free alternative to conventional tobacco cigarettes, but the health effects of "vaping" on humans have been debated in the scientific and tobacco manufacturing communities.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
Disabled people in Botswana have been largely excluded from the country's HIV/AIDS efforts, disability advocates said at a recent two-day workshop, Botswana's Mmegi reports.
› Verified 4 days ago